NCBI PubMed Central
open access
CXCR4-Targeted Nanotherapeutics: A Promising Approach for Liver Fibrosis and Hepatocellular Carcinoma Management.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study#911941
- Mid-zone hepatocytes trade proliferation for survival via Atf4-Chop axis in early acute liver injury#477987
- Mitogen-activated protein kinase kinase 4 (MKK4) as a promising therapeutic target in liver diseases: a review#4739
- IDENTIFICATION OF NANOBODIES AGAINST HFABP4 FROM A SYNTHETIC NANOBODY LIBRARY USING PURE RIBOSOME DISPLAY#330639
- HCC Risk Prediction Model Based on Multimodal Data in Chronic Hepatitis B#1032605
Record · ID 135921
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive